|
tofacitinib Clinical Trials
4 actively recruiting trials across 3 locations
Also known as: Jakvinus, Xeljanz
Other1 trial
San Francisco, California1 trial
Trial of Sequential Medications AfteR TNFi Failure in Juvenile Idiopathic Arthritis
University of California Medical Center
Phase 3
Bethesda, Maryland1 trial
Safety of Tofacitinib, an Oral Janus Kinase Inhibitor, in Primary Sjogren Disease
National Institutes of Health Clinical Center
Phase 2
Omaha, Nebraska1 trial
Treatment of Rheumatoid Arthritis With DMARDs: Predictors of Response
University of Nebraska Medical Center
Phase 3
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.